- News
- UK
- Home News
Sam Eljamel is thought to have harmed dozens of patients and left some with life-changing injuries
Pa Scotland ReporterWednesday 26 November 2025 00:01 GMT
open image in galleryCampaigners including many former patients of Sam Eljamel had long called for the public inquiry (PA)
Get the free Morning Headlines email for news from our reporters across the world
Sign up to our free Morning Headlines email
Sign up to our free Morning Headlines email
Email*SIGN UPI would like to be emailed about offers, events and updates from The Independent. Read our Privacy notice
A public inquiry into neurosurgeon Sam Eljamel is to hear from key participants as they make their opening statements.
Mr Eljamel was head of neurosurgery at Ninewells Hospital in Dundee from 1995 until his suspension in December 2013.
During this time, he is thought to have harmed dozens of patients and left some with life-changing injuries.
The surgeon resigned from his post in May 2014 and removed himself from the General Medical Register the following year.
The Eljamel Inquiry into his professional practice was announced by the Scottish Government in September 2023 and its terms of reference were set out by Scottish Health Secretary Neil Gray earlier this year.
Its remit includes how concerns about Mr Eljamel were responded to by his employer NHS Tayside and whether the systems in place to protect patients were adequate.
Jamie Dawson KC, senior counsel to the inquiry, and Joanna Cherry KC, for the patient group, will make opening statements at a hearing in Edinburgh on Wednesday, as will Una Doherty KC for NHS Tayside and Laura Thomson KC for Scottish ministers.
open image in galleryThe inquiry’s remit includes how concerns about Mr Eljamel were responded to by his employer NHS Tayside and whether the systems in place to protect patients were adequate (PA Wire)On Thursday, the inquiry will hear statements on behalf of Healthcare Improvement Scotland, NHS Education for Scotland and the Royal College of Surgeons (Edinburgh).
The inquiry will also hear a submission on behalf of the Independent Clinical Review (ICR), which is not a core participant.
On Wednesday Mr Dawson will also provide detail about plans for future hearings for the inquiry, as it moves closer to the start of its evidential hearings in 2026.
Section one, the first block of hearings, will examine the background to the inquiry’s terms of reference including the roles of key bodies, individuals, policies and practices relevant to matters being looked at by the probe.
It will look at areas including the broad trajectory of Mr Eljamel’s career in Scotland, the types of work he undertook and the systems surrounding his NHS practice.
It will also examine the circumstances surrounding his appointment to the role of consultant neurosurgeon at Ninewells Hospital in Dundee in 1995, and other key roles and the complaints and feedback systems in place at NHS Tayside.
